Affordable Care Act offers prescription for opportunity

  • Article by: NEAL ST. ANTHONY , Star Tribune staff writer
  • Updated: March 31, 2013 - 9:39 AM

The Affordable Care Act and baby-boomer demographics place a premium on innovative companies that can control medical costs while improving outcomes.

hide

Matt Arens is president of Kopp Investment Advisors as well as a top-performing senior portfolio manager of its AccruHealth small-capitalization fund.

Photo: JOEL KOYAMA • joel koyama@startribune.com ,

CameraStar Tribune photo galleries

Cameraview larger

Matt Arens, president of Kopp Investment Advisors, also is senior portfolio manager of its AccruHealth small-capitalization fund, which has been a stellar performer in recent years, thanks to good-performing medical technology, drug and information-technology picks.

Lipper and Money Manager Review recently ranked AccruHealth the top performer among small-cap funds for the past three years. Arens, who has been following the health care industry since 1997, said he’s mindful of how the Affordable Care Act, also known as Obamacare, will change the health care business as it is fully rolled out next year.

 

Q: What has been the annualized return of AccruHealth over the past three years?

A: AccruHealth’s annualized return over the last three years was 26.3 percent, compared to 12.8 percent for the Russell 2000 Growth Index. Since its inception in September 2008, AccruHealth has annualized returns of 24.66 percent, compared to 8.26 percent for the Russell 2000 Growth Index.

 

Q: What have been two or three of the best performers and why?

A: One of the best performers is Cepheid [ticker: CPHD], which provides a test to quickly detect staph infections patients acquire during hospital stays. Under new health care reform policies, hospitals are no longer reimbursed for treating hospital-acquired infections and, in the near future, Medicare/Medicaid reimbursement for all of a hospital’s services will be cut by 1 percent if it falls into the “worst-performing quartile” in this area. These policies provide a huge incentive for hospitals to adopt Cepheid’s solution to reduce the frequency and spread of these types of infections.

Another “best performer” is Spectranetics Corp. [SPNC]. One of its core medical devices opens blocked arteries in legs, which helps reduce the frequency of debilitating and costly amputations.

Additionally, in the health care space, a typical path to success for a small company is to be acquired, locking in gains for stockholders. One of the biggest drivers behind AccruHealth’s performance has been the propensity for portfolio companies to be acquired for a significant premium — some as high as 170 percent. Fifteen portfolio companies have been acquired since AccruHealth’s inception 17 quarters ago, including local companies Medtox, ATS Medical and American Medical Systems.

 

Q: How many stocks in the portfolio?

A: There are generally 35 to 45 different stocks in the AccruHealth portfolio. Currently, there are 41 stocks in the portfolio.

 

Q: How have you positioned the portfolio for ongoing health care reform?

A: Whether it’s government efforts, such as the Affordable Care Act, or new policies implemented by insurance companies, the overall goal for the health care system is to provide better care. Health care providers are being [pushed] to deliver better outcomes at lower costs. Companies in the AccruHealth portfolio offer innovative solutions that help providers operate more effectively within this new environment. I look for small companies in the sweet spot of innovation — larger than start-ups ... but smaller than established industry titans. They are “hungry” companies that have the critical mass to reduce investment risk, combined with solid business models.

 

Q: Are there companies that actually address some of the cost drivers in the system?

  • related content

  • About Matt Arens

    Saturday March 30, 2013

    Job: President and senior portfolio manager, Kopp Investment AdvisorsPersonal: Married, two childrenCareer: Joined Kopp in 1997 as research associateEducation: B.S.,...

  • get related content delivered to your inbox

  • manage my email subscriptions

ADVERTISEMENT

Connect with twitterConnect with facebookConnect with Google+Connect with PinterestConnect with PinterestConnect with RssfeedConnect with email newsletters

ADVERTISEMENT

Advertisement
Golden Gavel by Star Tribune

Countdown to great deals

Bid Sept. 21-29

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

 
Close